Law360 (December 16, 2020, 10:17 PM EST) -- Consumer-lending firm Upstart Holdings Inc. and tumor-focused drug developer BioAtla Inc. went public on Wednesday to receptive investors after raising $429 million combined under guidance from four law firms, continuing the initial public offerings market's late-year surge.
Wilson Sonsini Goodrich & Rosati PC advised Upstart, which raised $240 million after selling more than 12 million shares at $20 each, marking the low end of its price range of $20 to $22. Sullivan & Cromwell LLP represented the underwriters.
BioAtla raised $189 million, advised by Dechert LLP. The company sold 10.5 million shares at $18, beating its range of $15 to $17....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!